5TWL

Structure of Maternal Embryonic Leucine Zipper Kinase

5TWL の概要

• エントリーDOI: 10.2210/pdb5twl/pdb
• 関連するPDBエントリー: 5TVT 5TWU 5TWY 5TWZ
• 分子名称: Maternal embryonic leucine zipper kinase, 9-(3,5-dichloro-4-hydroxyphenyl)-1-{trans-4-[(dimethylamino)methyl]cyclohexyl}-3,4-dihydropyrimido[5,4-c]quinolin-2(1H)-one (3 entities in total)
• 機能のキーワード: kinase inhibitor, basal-like breast cancer, transferase-transferase inhibitor complex, transferase/transferase inhibitor
• 由来する生物種: Homo sapiens (Human)
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 39881.07

構造登録者

Seo, H.-S.,Huang, H.-T.,Gray, N.S.,Dhe-Paganon, S. (登録日: 2016-11-14, 公開日: 2017-11-22, 最終更新日: 2024-03-06)

主引用文献

Huang, H.T.,Seo, H.S.,Zhang, T.,Wang, Y.,Jiang, B.,Li, Q.,Buckley, D.L.,Nabet, B.,Roberts, J.M.,Paulk, J.,Dastjerdi, S.,Winter, G.E.,McLauchlan, H.,Moran, J.,Bradner, J.E.,Eck, M.J.,Dhe-Paganon, S.,Zhao, J.J.,Gray, N.S.
MELK is not necessary for the proliferation of basal-like breast cancer cells.
Elife, 6:-, 2017

PubMed Abstract: Thorough preclinical target validation is essential for the success of drug discovery efforts. In this study, we combined chemical and genetic perturbants, including the development of a novel selective maternal embryonic leucine zipper kinase (MELK) inhibitor HTH-01-091, CRISPR/Cas9-mediated MELK knockout, a novel chemical-induced protein degradation strategy, RNA interference and CRISPR interference to validate MELK as a therapeutic target in basal-like breast cancers (BBC). In common culture conditions, we found that small molecule inhibition, genetic deletion, or acute depletion of MELK did not significantly affect cellular growth. This discrepancy to previous findings illuminated selectivity issues of the widely used MELK inhibitor OTSSP167, and potential off-target effects of MELK-targeting short hairpins. The different genetic and chemical tools developed here allow for the identification and validation of any causal roles MELK may play in cancer biology, which will be required to guide future MELK drug discovery efforts. Furthermore, our study provides a general framework for preclinical target validation.

PubMed: 28926338
DOI: 10.7554/eLife.26693

実験手法

X-RAY DIFFRACTION (2.42 Å)